Company Filing History:
1 out of 3,221 
1 out of 39 
Years Active: 2021
Title: The Innovative Contributions of Robert Gentleman
Introduction
Robert Gentleman is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of cancer research through his innovative methods for diagnosing and treating cancer. His work focuses on the NRF2 gene and its implications in cancer treatment.
Latest Patents
Robert Gentleman holds a patent for "Methods for diagnosing and treating cancer by means of the expression status and mutational status of NRF2 and downstream target genes." This invention provides methods for identifying subjects with cancer, such as lung cancer, by analyzing the expression levels of NRF2 splice variants or target genes. Additionally, it outlines methods for treating cancer using NRF2 pathway antagonists in subjects who express these variants or overexpress target genes. He has 1 patent to his name.
Career Highlights
Throughout his career, Robert Gentleman has worked with prominent companies in the biotechnology sector. He has been associated with Genentech, Inc. and Foundation Medicine, Inc., where he contributed to groundbreaking research and development in cancer diagnostics and treatment.
Collaborations
Robert has collaborated with esteemed colleagues, including Christiaan Nicolaas Klijn and James M Lee, to advance the understanding and treatment of cancer.
Conclusion
Robert Gentleman’s innovative work in cancer research exemplifies the impact of scientific inquiry on medical advancements. His contributions continue to influence the field and offer hope for improved cancer diagnostics and therapies.